Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy.
Finsterer
Josef
J
Krankenanstalt Rudolfstiftung, Vienna, Austria. fifigs1@yahoo.de
Stöllberger
Claudia
C
D002313:Cardiomyopathy, Restrictive / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008659:Metabolic Diseases / Q000150:complications; D008875:Middle Aged; D009135:Muscular Diseases / Q000150:complications; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone